NASDAQ: SGMT
Sagimet Biosciences Inc Stock Ownership - Who owns Sagimet Biosciences?

Insider buying vs selling

Have Sagimet Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David HappelPresident CEO2025-07-2165,478$9.14
$598.14kSell
Eduardo Bruno MartinsChief Medical Officer2025-07-218,277$9.14
$75.61kSell
Elizabeth RozekGeneral Counsel and CCO2025-07-2110,780$9.14
$98.48kSell

1 of 1

SGMT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SGMT insiders and whales buy or sell their stock.

SGMT Shareholders

What type of owners hold Sagimet Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Patrick J. Kerins9.27%3,013,414$22.63MInsider
Forest Baskett9.26%3,011,575$22.62MInsider
Scott D. Sandell9.25%3,007,272$22.58MInsider
New Enterprise Associates 13 LP9.23%3,000,275$22.53MInsider
Nea Partners 13 Limited Partnership9.23%3,000,275$22.53MInsider
Woodline Partners LP7.85%2,552,536$19.17MInstitution
Beth C. Seidenberg6.25%2,031,118$15.25MInsider
Kpcb Pbd Associates LLC5.84%1,899,475$14.27MInsider
Jinzi Jason Wu5.09%1,654,701$12.43MInsider
Blue Owl Capital Holdings LP4.08%1,328,351$9.98MInstitution

1 of 3

SGMT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SGMT34.93%65.07%Net SellingNet Selling
HUMA35.97%19.03%Net SellingNet Selling
PRQR37.56%0.00%
CDXS48.24%51.76%Net BuyingNet Buying
FENC3.80%96.20%Net SellingNet Selling

Sagimet Biosciences Stock Ownership FAQ

Who owns Sagimet Biosciences?

Sagimet Biosciences (NASDAQ: SGMT) is owned by 35.90% institutional shareholders, 66.88% Sagimet Biosciences insiders, and 0.00% retail investors. Patrick J. Kerins is the largest individual Sagimet Biosciences shareholder, owning 3.01M shares representing 9.27% of the company. Patrick J. Kerins's Sagimet Biosciences shares are currently valued at $22.63M.

If you're new to stock investing, here's how to buy Sagimet Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.